This study demonstrates severe malformations of the appendicular skeleton in mice overexpressing Hoxc11. Consistent with the endogenous expression pattern, the most conspicuous defect in Hoxc11 overexpressing neonates is aplasia/hypoplasia of the ®bula. This is preceded at day 15.5 of embryonic development by marked reduction of chondrocyte proliferation, lack of PTHR expressing prehypertrophic cells, and the absence of hypertrophic and calcifying chondrocytes. Combined with the lack of an overt phenotype in the majority of Hoxc11 overexpressing embryos at day 13.5, the data suggest inhibition of chondrocyte differentiation during the elongation phase of the ®bula bone as a primary effect of elevated Hoxc11 expression. This interpretation is further corroborated by Hoxc11 reporter gene expression in the joint areas at embryonic day 15.5, suggesting an involvement of the periarticular perichondrium in generating the mutant phenotype. q
Introduction
The murine Hox gene system consists of a highly conserved family of homeobox genes organized into four non-linked clusters termed Hoxa, Hoxb, Hoxc, and Hoxd (Scott, 1992) . These genes encode transcription factors known to play key roles in development. The four Hox gene clusters share the same 5 H ±3 H polarity conferred by the uniform transcriptional orientation of the individual genes (McGinnis and Krumlauf, 1992) . In its 5
H region, each cluster contains a distinct subset of up to ®ve genes with homology to the Drosophila gene Abdominal B (AbdB). For several of these genes in the Hoxa and Hoxd cluster, different roles in fore-and hindlimb skeletal development have been well established by both loss-of-function and gain-of-function experiments in the mouse and chicken.
In particular, Hoxa11/Hoxd11 double homozygous loss-offunction mice are characterized by an almost total loss of the forelimb zeugopod bones radius and ulna (Davis et al., 1995) . In contrast, the hindlimb zeugopod is largely unaffected in those mice (ibd.), suggesting a potential role of other transcription factors, among them the paralogous Hoxc11, in hindlimb zeugopod development.
In contrast to the Hoxa and Hoxd genes, there are only limited functional data about AbdB related genes in the Hoxc cluster. We have previously isolated all ®ve AbdB related Hoxc genes, Hoxc13 through Hoxc9, and characterized the limb expression patterns of their mRNAs (Peterson et al., 1994) . These experiments demonstrated that the three neighboring genes Hoxc11, Hoxc10, and Hoxc9 were differentially expressed in the developing hindlimb, but not forelimb mesenchyme, implying a speci®c function for this subgroup of genes in hindlimb development.
The murine Hoxc11 mRNA hindlimb expression domain is posteriorly and proximally restricted during the zeugopod speci®cation stage (Peterson et al., 1994; Hostikka and Capecchi, 1998) . The strong similarity to the chicken Hoxc11 hindlimb expression pattern (Nelson et al., 1996) led us to hypothesize a conserved hindlimb speci®c function for Hoxc11, in particular for the development of the posterior zeugopod bone. In order to investigate whether Hoxc11 has the potential to affect hindlimb morphogenesis, we followed an approach pioneered by Wolgemuth et al. (1989) , where transgenic mice are generated that overexpress the Hox gene of interest in its natural expression domain. Such an approach may identify developmental pathways susceptible to imbalances in Hox gene expression not apparent in loss-of-function experiments.
Results

Transgenic overexpression approach to study Hoxc11 function in hindlimb development
We studied the presumed role of Hoxc11 in patterning the appendicular skeleton by overexpressing its genuine mRNA in transgenic mice speci®cally in its natural hindlimb expression domain. Two different Hoxc11 overexpression transgenes were used and they yielded very similar phenotypes (see below). Construct Gc11-L ( Fig. 1 ) is a mouse genomic DNA fragment of 20 kb containing the Hoxc11 transcription unit (Hostikka and Capecchi, 1998) , as well as 11.5 kb and 5 kb of upstream and downstream¯anking sequences, respectively. To better correlate the expression pattern of the transgene with the phenotypic alterations, a shorter overexpression transgene Gc11-S (Fig. 1) , where about 10 kb of upstream sequence is deleted, was also constructed. The smaller size of this construct allowed us to fuse the lacZ coding sequence in frame into the ®rst Hoxc11 exon (LZc11-S; Fig. 1 ). Thus, the expression pattern of Gc11-S could be conveniently monitored at high resolution by Xgal staining of LZc11-S transgenic embryos.
2.2. Hoxc11 transgene causes hindlimb overexpression, but no overt malformations in the majority of 13.5 dpc transgenic embryos
As the ®rst step in analyzing the phenotypic effects of the transgenes Gc11-L and Gc11-S, we investigated whether these constructs indeed caused overexpression of Hoxc11. We ®rst examined 13.5 dpc transgenic embryos. At this stage, the developing zeugopod and autopod are clearly distinguishable and the cartilage condensations giving rise to the zeugopod bones have formed. For Gc11-L, we generated a total of twelve independent transgenic embryos, of which nine (75%) showed no overt malformations. In situ hybridization with eight of those nine embryos revealed different extents of hindlimb Hoxc11 mRNA overexpression (Fig. 2B,C) , ranging from no increase over wild-type level to several-fold, when compared to non-transgenic littermates ( Fig. 2A) . These overexpression levels are apparently insuf®cient to generate an overt hindlimb phenotype at this stage, and they are not accompanied by detectable autopod expression. Hybridization with two of the three remaining transgenic embryos that had overt malformations of the hindlimbs (25%) revealed a correlation with extremely elevated and distally extended Hoxc11 hindlimb expression. In these mutant embryos, presumably ectopic autopod expression of Hoxc11 at high levels was present in addition to very strong Hoxc11 overexpression in the natural hindlimb domain (Fig. 2D ). In most Hoxc11 overexpressing embryos posterior proximal forelimb expression was observed ( Fig. 2C,D ; Table 1 ), whose level, while lower, was positively correlated with the level of hindlimb overexpression. This forelimb expression may not be ectopic, since we have recently found Hoxc11 mRNA in the forelimb mesenchyme of non-transgenic embryos, albeit at such low levels that the pattern de®es clear de®nition (data not shown).
For the 5 H -truncated overexpression construct Gc11-S the corresponding lacZ fusion construct LZc11-S was used to demonstrate the presence of the cis-regulatory elements required to drive expression in the proper 13.5 dpc hindlimb expression domain. Three independent transgenic mice were generated. One was transiently assayed at 12.5 dpc H region of the cosmid clone cos2W3A (Peterson et al., 1994) showing the presumed Hoxc11 exons (boxed) with protein coding regions (black). (Bottom) Transgene overexpression constructs subcloned from cos2W3A with schematic of Hoxc11 transcription unit and sizes of upstream and downstream¯anking regions indicated. Reporter gene construct generated by in frame insertion of lacZ using the genomic EagI sites. Restriction sites: E, EagI; S, SalI.
for reporter gene activity (Fig. 3A) and the other two were used as founders for transgenic lines. Embryos from both lines were assayed at 13.5 dpc by whole-mount Xgal staining ( Fig. 3B ) and showed a hindlimb expression pattern consistent with the endogenous Hoxc11 expression domain ( Fig. 2A) and with the hindlimb overexpression pattern in most Gc11-L embryos. It appears that the deletion of about 10 kb of upstream sequences ( Fig. 1) does not abolish the ability of the transgene to direct expression to a hindlimb expression domain that appears very similar to the endogenous Hoxc11 pattern. From Xgal stained sections at 13.5 dpc (not shown), we observed that reporter gene activity was not localized in the ®bula anlage itself, but rather in the perichondrium and surrounding mesenchyme, consistent with the expression pattern of the endogenous Hoxc11 mRNA in section in situ hybridization experiments reported by us and others (Peterson et al., 1994; Hostikka and Capecchi, 1998) . Interestingly, as development progresses to 15.5 dpc, reporter gene activity becomes concentrated over the ®bula joints (Fig. 3C ). These results suggest that the periarticular chondrocytes on the ends of the ®bula are main sites of LZc11-S and, by inference, of Gc11-S expression during the onset of endochondral ossi®cation in the ®bula. In addition to the hindlimb expression pattern, two of the three independent LZc11-S transgenics show posterior proximal forelimb expression at 12.5/13.5 dpc (Fig. 3A) in a similar pattern to the Gc11-L overexpressors (Fig. 2) .
The majority of Hoxc11 transgenic neonates exhibit speci®c hindlimb skeletal defects
Since the limb phenotype in 13.5 dpc Hoxc11 overexpres- Table 1 Frequencies of limb phenotype, overexpression and reporter gene expression among Hoxc11 transgenic mice Neonates (Gc11-L) Neonates (Gc11-S) 15.5 dpc (Gc11-L) 13.5 dpc embryos (Gc11-L overexpression) sing embryos had a low penetrance, our transgenic system was ideally suited to study the effect of Hoxc11 overexpression during the late fetal and neonatal stages of limb skeletal development. Indeed, transgenic late embryos and neonates showed characteristic skeletal defects with high penetrance (Table 1) . Gc11-L transgenic mice were analyzed at birth. Although poor survival made the analysis dif®cult (see Section 4), 14 transgenic neonates could be identi®ed. At this stage, a majority (10/14) showed overt limb malformations as shown in Fig. 4B ,C. About two-thirds of these mutants (7/10) had severe abnormalities restricted to the hindlimb and are here referred to as class H (Fig. 4B ). The other three neonates exhibited severe defects of both fore-and hindlimb (class FH; Fig. 4C ). Altogether, four class H and three class FH neonates were further analyzed by skeletal staining as shown in Fig. 4D±J . The most striking phenotype in all seven skeletons is the lack of the ®bula (compare Fig. 4G ,H to F) combined with an abnormal angle of femur articulation to the pelvis (compare Fig. 4E to D) apparently due to a malformed proximal femur. In addition, a variable mild fusion phenotype in the posterior tarsal region including a small ®bula vestige fused to the talus was observed (Fig. 4G) . Within either class H or class FH, the consistency of the zeugopod defects among the skeletons examined was the most striking observation. In addition to loss of the ®bula, the four skeletons belonging to class H all displayed slightly bent tibiae, and comparatively normal hindlimb autopods and distal femurs ( Fig. 4G ) as well as forelimb skeletons. Minor malformations sometimes found in the class H animals included occasional presence of a sixth ray rudiment in the hindlimb and sporadic absence of the deltoid tuberosity of the humerus, but no other forelimb defects were ever observed (data not shown). In the three class FH skeletons, the general hindlimb phenotype was more severe than in the class H animals. In addition to the loss of the ®bula, their hindlimb zeugopod defects included severely misshapen and reduced tibiae (Fig. 4H ).
Other elements showing hypoplasia were the pelvis and in two of the animals, the hindlimb autopod with reduced number of digital rays (data not shown). In the forelimb, all three class FH skeletons had a selective, pronounced reduction of the ulna bone (compare Fig. 4J to I), always with concomitant bending of the radius. One bilateral and one unilateral occurrence of missing deltoid tuberosity from the humerus (Fig. 4J ) were observed among the three FH mutants.
In order to better correlate the phenotypic consequences to the pattern of Hoxc11 overexpression, we examined another set of transgenic mice carrying Gc11-S, whose expression pattern was monitored by its lacZ reporter counterpart LZc11-S ( Fig. 3 ) and found to be essentially identical to that of endogenous Hoxc11 and Gc11-L. As expected, no phenotype was observed in LZc11-S transgenic mice, where the transgene has a disrupted Hoxc11 transcription unit. Gc11-S neonates, however, exhibited hindlimb and forelimb abnormalities similar to those observed in the more severe FH group of Gc11-L mice.
A total of three mutant mice were harvested at 19.0 dpc (i.e. a few hours before birth), all of which exhibited limb malformations similar to those seen in the FH class of the Gc11-L mutant neonates. Interestingly, skeletal staining revealed size reductions of the ulna bones in all three animals (Fig. 4K) . In the hindlimbs, two of the animals exhibited absence and severe fusion of skeletal elements in the autopod (Fig. 4L) . The zeugopod bones were heavily affected in all three Gc11-S mutants, which invariably included dramatic reductions of the tibia (Fig. 4L,M) in addition to the ®bula phenotype. In one case, a unilateral severe reduction of the ossi®ed region of the femur was observed (Fig. 4M , red staining) combined with absence of the pubic portion of the pelvis. In summary, the abnormalities in the Gc11-S mutants are similar to those in the Gc11-L mutants, but on average more severe with respect to autopod, femur and tibia involvement as well as the high frequency of ulna reductions. This may indicate a higher level of expression from the Gc11-S construct compared to Gc11-L, possibly due to the removal of repressing elements in the deleted 10 kb of upstream sequence.
Hoxc11 overexpression disrupts chondrocyte differentiation in the 15.5 dpc ®bula
While the majority of Hoxc11 overexpression transgenic neonates (10/14) exhibited overt changes in hindlimb morphology concomitant with the consistent skeletal abnormality of ®bula loss, only a minority of two mutant newborns had major autopod malformations. Remarkably, at age 13.5 dpc there was a majority of Gc11-L transgenic embryos (9/12) lacking an overt hindlimb phenotype but showing moderate overexpression of Hoxc11 mRNA, while only a minority of three embryos already presented hindlimb malformations including the autopod mirrored by strong over-and presumably ectopic autopod expression. We conclude that in the majority of Gc11-L mutants, the ®bula phenotype manifests itself later than 13.5 dpc. Since the cartilaginous condensations of the long bones are already present at 13.5 dpc, this suggests that in the majority of Gc11-L mutants, the later cartilage differentiation and concomitant ®bula outgrowth, rather than the initial pattern formation, is the process mainly affected by Hoxc11 overexpression. In order to test whether an effect on ®bula growth could already be detected at the initial stage of bone outgrowth, Gc11-L transgenic embryos were analyzed at 15.5 dpc, when the wild-type ®bula has started the process of elongation. At this stage, the differentiation of small, proliferating chondrocytes into hypertrophic chondrocytes has begun and calci®cation is occurring in the medial region of the wild-type ®bula. A total of eight transgenic 15.5 dpc Gc11-L embryos was obtained (Table  1) , of which ®ve were harvested for the analysis described here. (The remaining three were used for the immunocytochemistry experiments described below, 2.5). Among the ®ve 15.5 dpc Hoxc11 transgenic embryos obtained, a majority (4/5) displayed essentially identical overt hindlimb malformations but with an apparently normal autopod. Thus, all four apparently represented moderate Gc11-L overexpression mutants. To characterize their malformations in detail, two of the mutant embryos were subjected to whole-mount skeletal staining with Alizarin red and Alcian blue, while the remaining two embryos were used for histological analysis of the hindlimb phenotype in tissue sections. Both 15.5 dpc mutant embryos subjected to whole-mount skeletal staining had virtually identical hindlimb abnormalities as shown in Fig. 5A . The mutant ®bula shows no central calci®ed region as present in the wild-type littermate (Fig. 5D ) and the size of the ®bula cartilage stained by Alcian blue is much reduced. By comparison, the size of the mutant tibia is relatively little affected, although it shows bending in its distal portion not observed in the wild type. When cryosections through the entire mutant hindlimbs of the remaining two embryos were subjected to H&E staining, it was revealed that the ®bula in the mutants consists entirely of small, presumably undifferentiated, chondrocytes not undergoing hypertrophy (Fig. 5B) . In contrast, the wildtype ®bula (Fig. 5E ) and also wild-type and mutant tibia (Fig. 5B,E) have broad zones of hypertrophic cartilage, while the small, undifferentiated chondrocytes are con®ned to the distal regions. In addition, the mutant embryos showed a fusion of the ®bula to the talus bone (Fig. 5B) , which was never observed in the wild type. Staining tissue sections for alkaline phosphatase (AP, a marker for calcifying cells) activity revealed the absence of AP-positive cells from the mutant ®bula (Fig. 5C ), while the shafts of wild-type ®bula and both wild-type and mutant tibia are surrounded by AP-positive cells (Fig. 5C,F) . This absence of calcifying cells from the mutant ®bula is consistent with its lack of whole-mount Alizarin red staining (Fig. 5A) . Furthermore, the Alcian blue-stained ®bula structure in any hindlimb of the two whole-mount stained mutant embryos is smaller compared to the ®bula size revealed by hindlimb sections at the same age. Therefore, it appears that the abundance of sulfated proteoglycans, which are detected by Alcian blue, is reduced in the mutant ®bula compared to the wild type. In summary, the data obtained from the 15.5 dpc embryos indicate that although the cartilage anlagen of the hindlimb zeugopod form in the Hoxc11 overexpression mutant mice, the ®bula cartilage fails to differentiate properly, not allowing the process of endochondral ossi®cation to take place normally. The LZc11-S reporter gene activity in the joint regions that we observe at this stage in development (Fig. 3C) implicates the periarticular perichondrium as the tissue where abnormal signaling is responsible for the block of chondrocyte differentiation.
Evidence for reduced chondrocyte proliferation and lack of PTHR expression in mutant ®bula
As a ®rst step towards gaining insight into the cellular mechanisms affected by Hoxc11 overexpression, two characteristic aspects of proper growth plate activity in the 15.5 dpc mutant ®bulae were investigated by immunocytological methods. Accordingly, we analyzed proliferation rates by BrdU assays and the distribution of an early marker for prehypertrophic chondrocytes, namely PTH/PTHrP-receptor (PTHR). For these studies, three Gc11-L transgenic fetuses were subjected to in vivo BrdU labeling at 15.5 dpc (see Section 4). All three transgenic embryos used for this experiment had hindlimb malformations. One of these embryos exhibited a normal autopod combined with mild ®bula reduction and was therefore considered a member of the majority class of moderate Hoxc11 overexpressors, whereas the other two had more severe malformations. Hindlimbs from all three mutant embryos were used for the subsequent studies and yielded similar results. BrdU incorporation in the Gc11-L transgenic ®bulae (Fig. 6A ) was dramatically reduced, if not abolished compared to wild-type littermates (Fig. 6C) . This must be a genuine biological effect of Hoxc11 overexpression as the connective tissue exterior to the bone is labeled to a similar degree in mutant and wild-type sections (compare Fig. 6A to C) . In wild-type long bone development, there is a well-organized zone of proliferating chondrocytes preceding the prehypertrophic zone. While these proliferating chondrocytes were clearly visualized by their BrdU incorporation in the wildtype ®bula, the mutant ®bula had no organized zone of proliferation but instead far less and sporadic BrdU incorporating chondrocytes.
The BrdU data indicating an early perturbation of chondrocyte differentiation in the proliferating zone of the developing growth plate were con®rmed by anti-PTHR antibody staining of sections from the same preparations. Polyclonal antibodies to PTHR revealed that there were no PTHR-positive chondrocytes in the Gc11-L mutant ®bulae at 15.5 dpc (Fig. 6B) . This was in contrast to the wild-type ®bula, which had a zone of strongly PTHR expressing prehypertrophic chondrocytes in its central region (Fig. 6D) where the developing growth plates are located at this stage.
In summary, the proliferation and PTHR data both indicate that chondrocyte differentiation in the mutant ®bula is disrupted at an early stage not allowing for proper growth plate formation.
Discussion
Hoxa11/Hoxd11 double loss-of-function yields a dramatic forelimb, but only mild hindlimb zeugopod phenotype (Davis et al., 1995) , suggesting compensation by other factors. Among the obvious candidates are Hoxc11 and its 3 H neighbors Hoxc10 and Hoxc9, which all show differential hindlimb expression (Peterson et al., 1994) . Hindlimb identity is apparently linked to expression of T-box gene Tbx4 (Gibson-Brown et al., 1998; Isaac et al., 1998; Logan et al., 1998) and the bicoid-related factor Pitx1 (Shang et al., 1997; Logan et al., 1998) . Pitx1 loss-of-function in the mouse partially transforms the hindlimb skeleton towards forelimb identity (Szeto et al., 1999) , whereas Pitx1 misexpression in the chick forelimb leads to a hindlimb-like phenotype (ibd.; Logan and Tabin, 1999) . Interestingly, ectopic Pitx1 is capable of inducing Tbx4, Hoxc11, and Hoxc10 expression in the developing chick forelimb (Logan and Tabin, 1999) . The data suggest that in wild-type hindlimb development Pitx1 activates Hoxc11, probably mediated by Tbx4. Taken together with the late Hoxc11 reporter gene expression in speci®c hindlimb joints reported here (Fig. 3C ), it appears that Hoxc11 is likely involved in the implementation of hindlimb identity established by Pitx1 and the T-box genes.
In a number of situations with elevated limb expression of AbdB-related Hox genes (Morgan and Tabin, 1994; Yokouchi et al., 1995; Van der Hoeven et al., 1996; Goff and Tabin, 1997; He Ârault et al., 1997; Knezevic et al., 1997; Peichel et al., 1997) inhibitory effects on bone size have been observed, but were generally mild within the natural expression domains of the genes in question. In contrast, the ®bula phenotype reported here correlates well with the wildtype Hoxc11 expression pattern and is consistently very severe. We show an apparent early block of chondrocyte differentiation in the developing ®bula indicated by dramatically reduced number of proliferating cells and absence of PTHR expressing prehypertrophic cells, which leads to virtual elimination of the ®bula. Thus, the apparently very high potency of the Hoxc11 gene product to inhibit endochondral ossi®cation in the mutant ®bula indicates a great susceptibility of the tissues where Hoxc11 is normally expressed to elevated levels of Hoxc11 expression, profoundly changing long bone development.
The morphogenesis of the long bones is thought to employ a feedback loop controlling the rate of chondrocyte differentiation Vortkamp et al., 1996) . The Hoxc11 reporter gene expression pattern over the ®bula joints suggests Hoxc11 expression in the periarticular perichondrium, which secretes PTHrP as a paracrine signal to the differentiating chondrocytes expressing PTHrP/PTH receptor. Interestingly, PTHrP loss-of-function mice exhibit accelerated chondrocyte differentiation and premature endochondral ossi®cation (Karaplis et al., 1994) . Targeted overexpression of PTHrP in chondrocytes under the control of the type II collagen promoter in transgenic mice results in retardation of chondrocyte differentiation concomitant with reduced size of long bones and delayed and abnormal endochondral ossi®cation (Weir et al., 1996) . At birth, no ossi®cation of the long limb bones has been observed in these mice. As this phenotype is super®cially similar to the ®bula phenotype observed in our Hoxc11 overexpression mice, it appears tempting to implicate elevated PTHrP secretion as a potential downstream effector of Hoxc11 overexpression.
While our immunohistochemical data support an effect of Hoxc11 overexpression on the PTHrP system at the receptor level, the apparent drastic reduction in chondrocyte proliferation may point to blocks at even earlier steps of bone growth control. The phenotypic consequences in the limb skeleton of introducing extra copies of the Hoxc11 gene into the murine genome likely re¯ect two separate aspects of Hoxc11 expression in the mutant mice. The ®rst aspect is Hoxc11 overexpression in the developing zeugopod, which was the intention of this study. The observed outcome is that endochondral ossi®cation of the long bones of the hindlimb zeugopod is affected in all mutants. In the majority of Gc11-L mutant neonates this effect is largely restricted to impaired outgrowth of the ®bula in combination with a malformed proximal femur and bowing of the tibia, whereas in the more severe Gc11-L and all Gc11-S mutants the tibia, too, is much reduced in size. Concomitant with the impaired ®bula outgrowth and manifest at 15.5 dpc, a disruption of ankle joint formation, most notably a fusion between the vestige of the ®bula and the talus bone, is present. The second aspect of hindlimb Hoxc11 overexpression in the mutant mice is that as a side effect the autopod is sometimes included in the expression domain, which can be seen as early as 13.5 dpc concomitant with a malformed footplate at this stage. This is mirrored by complete absence of whole skeletal elements in the autopods of severely affected mutant neonates. These defects may result from a reduced number of mesenchymal precursor cells available for the formation of cartilaginous condensations.
It is interesting that the three processes implicated in the Hoxc11 mutant hindlimb, i.e. (i) limb mesenchyme reduction, (ii) joint formation, and (iii) endochondral ossi®cation, are all regulated by BMP signaling. BMP2 and BMP7 have been shown to be potent inducers of apoptosis in the undifferentiated chick limb mesenchyme, resulting in the complete lack of some skeletal elements (Macias et al., 1997; Zou et al., 1997a) . At a later stage, injection of BMP2 has been demonstrated to alter joint shape in chick limbs, whereas BMP7 could inhibit joint formation altogether (Macias et al., 1997) . Likewise, joint formation could be inhibited by infection of limb buds with replication competent retroviruses expressing type I BMP receptors (Zou et al., 1997b) . Furthermore, one of the two type I receptors, namely BMPR-IA is expressed in the joint regions (as well as the inner layer of the perichondrium). Overexpression of constitutively active BMPR-IA causes delay in chondrocyte differentiation (Zou et al., 1997b) , likely acting through the PTH/PTHrP pathway Vortkamp et al., 1996) . The similarities between the phenotype in the Hoxc11 overexpression mice and the effects seen upon increased BMP signaling suggest that Hoxc11 overexpression may exert its effect by modulating BMP signaling, possibly by upregulating the transcription of BMP receptors.
Data from an overexpression study of Hoxc8 using a binary transgenic system (Yueh et al., 1998) suggest that Hoxc8 expression in proliferating and prehypertrophic chondrocytes modulates their differentiation. At ®rst sight, this seems a different phenomenon entirely from the action of Hoxc11 in the periarticular perichondrocytes that we propose here. However, the prehypertrophic as well as the periarticular chondrocytes are both expressing BMPR-IA. Thus, it appears possible that Hoxc8 and Hoxc11 exert their effect on chondrocyte differentiation by similar cellular mechanisms that modulate BMP responsiveness.
The skeletal alterations observed in this study, in particular the ®bular aplasia/hypoplasia in combination with proximal femur defects and occasional ulnar involvement were reminiscent of the ®bular developmental ®eld which has been de®ned based on the phenotypes of human congenital malformations (Lewin and Opitz, 1986) . It could be interesting to investigate whether Hoxc11 is involved in the pathogenesis of human conditions where the ®bular ®eld is affected. Improved knowledge of Hoxc11 function and regulation and the factors it interacts with in the mouse will potentially contribute to our understanding of human disease.
Experimental procedures
Generation of transgenic mice
The genomic cosmid clone cos2W3A (Peterson et al., 1994 ) from a CD-1 outbred genomic DNA library in the SuperCos (Stratagene) vector was digested with NotI and SalI and the resulting 20 kb Hoxc11 genomic fragment subcloned into NotI±SalI digested pBluescriptIISK(1) to generate pGc11-L. The 10 kb fragment located 3 H in pGc11-L was excised with Acc65I and cloned into the Acc65I site of pUC19 to generate pGc11-S. To generate pLZc11-S, pGc11-S was cleaved with EagI and end®lled, and the internal EagI fragment was replaced with the end®lled Acc65I±HindIII fragment from pLZRVB (Bieberich et al., 1990) , creating an in-frame fusion of the Hoxc11 and lacZ coding sequences.
The transgenes were then released from the plasmid vectors by restriction with suitable enzymes and puri®ed by sucrose gradient centrifugation. Transgenic mice were generated by pronuclear microinjection of FVB/N zygotes following established procedures (Hogan et al., 1994) . The injected zygotes were transferred to the oviducts of pseudopregnant CD-1 females.
Genotyping
Transgene Gc11-L was detected by the polymerase chain reaction (PCR) using primers 5
H -AGAAGGATCCAAC-TTGTCATTTTCC-3 H and 5 H -ATCTACGGAACTCGGA-CTGCCAACC-3 H which span the boundary between two consecutively integrated copies of the transgene. Genomic DNA from neonates for genotyping was prepared at dissection from tail clippings or skin patches. The total of 14 transgenic newborn mice includes two class H mutants (see Section 2) that could not be genotyped due to cannibalization by the foster mother and one class H mutant that tested negative in the PCR assay. Gc11-L injected embryos harvested at 13.5 dpc for analysis of transgene expression were genotyped by PCR on genomic DNA from extraembryonic membranes and twelve transgenic embryos were identi®ed. Embryos harvested at 15.5 dpc were screened using head genomic DNA, and ®ve PCR-positives were identi®ed.
Screening for transgene Gc11-S was carried out with primers 5 H -AGAAGGATCCAACTTGTCATTTTCC-3 H and 5 H -ACAACAATACTTCGGTGAAATCTGC-3 H by PCR across the boundary of consecutive transgene copies using genomic DNA from 19.0 dpc heads, identifying three transgenics. For construct LZc11-S, two transgenic lines and one transient expressor were identi®ed by PCR on DNA from tail and extraembryonic membranes, respec-tively, using lacZ primers 5 H -GCATCGAGCTGGGTAA-TAAGCGTTGGCAAT-3 H and 5 H -GACACCAGACCAAC-TGGTAATGGTAGCGAC3-H (Bonnerot and Nicolas, 1993, corrected) .
Analysis of transgenic phenotypes
To analyze the limb phenotype in Gc11-L transgenic mice, microinjected embryos were allowed to develop to term, monitored at birth for abnormalities, and screened for presence of the transgene by PCR. Among the ten mice with mutant limb phenotypes, nine were stillborn or died within 2 days after birth. Skeletal staining of newborn mice and 15.5 dpc embryos was performed as described (Hogan et al., 1994) .
For histological analysis, 15.5 dpc hindlimbs were dissected in PBS, ®xed for 1 h in 1% formaldehyde (Polysciences), 1£ PBS on ice, incubated overnight in 20% Sucrose, 50 mM EDTA, 1£ PBS at 48C and embedded in OCT (Miles Scienti®c) medium. Ten-mm frozen sections were dried on a 358C slide warmer and acetone-®xed. They were then subjected to H&E staining or to alkaline phosphatase detection using the Sigma leukocyte alkaline phosphatase kit with subsequent hematoxylin counterstaining.
Whole-mount Xgal staining of embryos was done as described (Papenbrock et al., 1998) . For Xgal staining of sections, a modi®cation of the protocol posted at http://www.pitt.edu/~carthew/manual/Head.html was used. Brie¯y, fresh 15.5 dpc hindlimbs were embedded in OTC, 25-mm sections were transferred to silane adhesive coated slides (Electron Microscopy Sciences), warmed to 508C, air dried and ®xed in 0.5% glutaraldehyde for 30 min. After two 10-min washes with PBS, slides were incubated for 24 h at 378C in 1£ PBS, 20 mM Tris±HCl (pH 7.3), 10 mM K 3 (Fe(CN) 6 ), 10 mM K 4 (Fe(CN) 6 ), 2 mM MgCl 2 , 0.5 mg/ ml Xgal (from 100 mg/ml Xgal stock in dimethylformamide). The sections were then washed with PBS, EosinYcounterstained and mounted in Permount (Fisher).
Immunocytochemistry
Foster mothers were injected with BrdU (Sigma, St. Louis, MO) at 200 mg/kg in 0.9% NaCl I.P. in two locations. Mice were killed by cervical dislocation after 2 h. Embryos were harvested in ice cold EPBS and inspected for limb truncation. After the tail was removed for genotyping, hindlimbs were removed and ®xed in fresh 3% buffered paraformaldehyde for 30 min. The limbs were subsequently rinsed in PBS and dehydrated in graded ethanols. The limbs were subsequently embedded in paraf®n and sectioned at 5 mm. After sectioning, the tissue was cleared of paraf®n and rehydrated through graded ethanol to PBS. To detect BrdU uptake, the rehydrated sections were treated with 4 N HCl for 30 min to denature the DNA. Afterward, pH was neutralized with 100 mM sodium tetraborate. The tissue was permeabilized with 0.1% Triton X-100 and rinsed brie¯y in PBS. Sections were subsequently blocked for 30 min in 3% BSA/10% rat serum in PBS. The sections were labeled with FITC-conjugated rat anti-BrdU (Harlan Sera-Lab, Loughborough, UK), diluted in 3% BSA/10% rat serum in PBS for 1 h in a humid chamber at room temperature. After copious washing in PBS, the slides were coverslipped for viewing. To examine the limbs for expression of PTHR, adjacent sections to those processed for BrdU labeling were blocked in 3% BSA in PBS containing 5% rabbit serum. This was followed by a 1 h incubation with rabbit anti-rat PTHR (BABCO, Richmond, CA) at 10 mg/ml in 3%BSA in PBS. This polyclonal antibody was generated against a rat PTHR peptide which is 100% conserved in murine PTHR. After rinsing in PBS, primary antibody was immunolocalized with FITC-conjugated goat antirabbit IgG (Jackson Immunoresearch Labs, West Grove, PA), 10 mg/ml in 3% BSA in PBS. Micrographs were generated on a research-grade LeitzTM photomicroscope equipped with a PhotometricsTM (Tuscon, AZ) Quantix CCD camera. The images were stored to an IBM workstation and processed using Adobe Photoshop.
Whole-mount in situ hybridization
Whole-mount in situ-hybridization to mouse embryos was performed as described (Hogan et al., 1994) . Hoxc11 probes were generated as follows. A 503-nucleotide fragment from the ®rst exon of Hoxc11 was ampli®ed by reverse transcription±PCR using downstream primer 5
H -GGAA-TTCCCGCATAACAAGACGAGT-3 H and upstream primer 5 H -GGAATTCTGCAAACCAATCGCCTGAAC-3 H , digested with EcoRI and cloned into the EcoRI site of pSAFYRE. Digoxigenin-labeled sense (control) and antisense probes were then made with Boehringer Mannheim kit by in vitro transcription using T7 and SP6 promoter, respectively.
Use of animals
Experimental procedures involving animals had been approved by the Institutional Animal Care and Use Committee (IACUC).
